These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23022131)

  • 1. Interplay of mycolic acids, antimycobacterial compounds and pulmonary surfactant membrane: a biophysical approach to disease.
    Pinheiro M; Giner-Casares JJ; Lúcio M; Caio JM; Moiteiro C; Lima JL; Reis S; Camacho L
    Biochim Biophys Acta; 2013 Feb; 1828(2):896-905. PubMed ID: 23022131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung surfactant dysfunction in tuberculosis: effect of mycobacterial tubercular lipids on dipalmitoylphosphatidylcholine surface activity.
    Chimote G; Banerjee R
    Colloids Surf B Biointerfaces; 2005 Nov; 45(3-4):215-23. PubMed ID: 16198543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a novel antimycobacterial compound on the biophysical properties of a pulmonary surfactant model membrane.
    Pinheiro M; Arêde M; Giner-Casares JJ; Nunes C; Caio JM; Moiteiro C; Lúcio M; Camacho L; Reis S
    Int J Pharm; 2013 Jun; 450(1-2):268-77. PubMed ID: 23603451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular interaction of Rifabutin on model lung surfactant monolayers.
    Pinheiro M; Lúcio M; Reis S; Lima JL; Caio JM; Moiteiro C; Martín-Romero MT; Camacho L; Giner-Casares JJ
    J Phys Chem B; 2012 Sep; 116(38):11635-45. PubMed ID: 22931247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of mycobacterial lipids on surface properties of Curosurf: implications for lung surfactant dysfunction in tuberculosis.
    Chimote G; Banerjee R
    Respir Physiol Neurobiol; 2008 Jun; 162(1):73-9. PubMed ID: 18515195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the structure-activity relationship of rifabutin and analogs: a drug-membrane study.
    Pinheiro M; Pereira-Leite C; Arêde M; Nunes C; Caio JM; Moiteiro C; Giner-Casares JJ; Lúcio M; Brezesinski G; Camacho L; Reis S
    Chemphyschem; 2013 Aug; 14(12):2808-16. PubMed ID: 23821530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keeping lung surfactant where it belongs: protein regulation of two-dimensional viscosity.
    Alonso C; Waring A; Zasadzinski JA
    Biophys J; 2005 Jul; 89(1):266-73. PubMed ID: 15833995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinations of fluorescently labeled pulmonary surfactant proteins SP-B and SP-C in phospholipid films.
    Nag K; Taneva SG; Perez-Gil J; Cruz A; Keough KM
    Biophys J; 1997 Jun; 72(6):2638-50. PubMed ID: 9168039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of mycolic acid on surface activity of binary surfactant lipid monolayers.
    Chimote G; Banerjee R
    J Colloid Interface Sci; 2008 Dec; 328(2):288-98. PubMed ID: 18848703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of levofloxacin with lung surfactant at the air-water interface.
    Ortiz-Collazos S; Estrada-López ED; Pedreira AA; Picciani PHS; Oliveira ON; Pimentel AS
    Colloids Surf B Biointerfaces; 2017 Oct; 158():689-696. PubMed ID: 28778052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary surfactant proteins SP-B and SP-C in spread monolayers at the air-water interface: II. Monolayers of pulmonary surfactant protein SP-C and phospholipids.
    Taneva S; Keough KM
    Biophys J; 1994 Apr; 66(4):1149-57. PubMed ID: 8038386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary surfactant proteins SP-B and SP-C in spread monolayers at the air-water interface: I. Monolayers of pulmonary surfactant protein SP-B and phospholipids.
    Taneva S; Keough KM
    Biophys J; 1994 Apr; 66(4):1137-48. PubMed ID: 8038385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-membrane interaction studies applied to N'-acetyl-rifabutin.
    Pinheiro M; Arêde M; Caio JM; Moiteiro C; Lúcio M; Reis S
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):597-603. PubMed ID: 23523541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temperature dependence of the Langmuir monolayer packing of mycolic acids from Mycobacterium tuberculosis.
    Villeneuve M; Kawai M; Kanashima H; Watanabe M; Minnikin DE; Nakahara H
    Biochim Biophys Acta; 2005 Sep; 1715(2):71-80. PubMed ID: 16125133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biophysical models in investigations of exogenous surfactant activities on the surface tension and their theurapeutic effectiveness].
    Todorov R; Iordanova A; Georgiev GA; Petkova Kh; Stoimenova E; Georgieva R; Khristova E; Vasiliev Kh; Lalchev Z
    Akush Ginekol (Sofiia); 2007; 46 Suppl 1():29-36. PubMed ID: 18175392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary surfactant protein SP-C causes packing rearrangements of dipalmitoylphosphatidylcholine in spread monolayers.
    Pérez-Gil J; Nag K; Taneva S; Keough KM
    Biophys J; 1992 Jul; 63(1):197-204. PubMed ID: 1420867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interfacial organizations of gel phospholipid and cholesterol in bovine lung surfactant films.
    Nag K; Fritzen-Garcia M; Devraj R; Panda AK
    Langmuir; 2007 Apr; 23(8):4421-31. PubMed ID: 17341098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of cholesterol and budesonide on biophysical properties of clinical surfactant.
    Zhang H; Wang YE; Neal CR; Zuo YY
    Pediatr Res; 2012 Apr; 71(4 Pt 1):316-23. PubMed ID: 22391630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospholipid packing and hydration in pulmonary surfactant membranes and films as sensed by LAURDAN.
    Picardi MV; Cruz A; Orellana G; Pérez-Gil J
    Biochim Biophys Acta; 2011 Mar; 1808(3):696-705. PubMed ID: 21126510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.